China vs New Zealand: Number of isolates tested for ceftriaxone
China
2,613
in 2020
New Zealand
861
in 2020
China rank
4th
New Zealand rank
7th
Number of isolates tested for ceftriaxone over time
- China
- New Zealand
How they compare
China currently reports 2,613 against 861 in New Zealand, a difference of 1,752.
That makes China's figure about 3.0 times New Zealand's.
Across all 7 years both countries report, China has been ahead every year.
China ranks 4th and New Zealand ranks 7th of 52 countries.
China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,398 | 234 | 1,164 | China |
| 2010s | 1,223 | 387.4 | 835.4 | China |
| 2020s | 2,613 | 861 | 1,752 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, China or New Zealand?
- China, at 2,613 against 861 in New Zealand as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between China and New Zealand?
- 1,752, with China ahead.
- How many years of comparable data are there for China and New Zealand?
- 7 years are reported by both, from 2009 to 2020.
- How do China and New Zealand rank globally for number of isolates tested for ceftriaxone?
- China ranks 4th and New Zealand ranks 7th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.